Dr. Wettig's research interests lie in the general areas of biophysical chemistry and nanotechnology; in particular at the interface of these two broadly defined areas.
This research involves aspects of physical chemistry, solution thermodynamics, biochemistry and cell biology applied to the study of self-assembling systems.
Festo is a registered pharmacist and holds a Bachelor of Pharmacy degree from the University of Dar es Salaam and a doctorate degree in Pharmaceutics from Catholic University of Leuven.
Shruti holds a Masters degree in BioMedical Engineering (McGill University) and a Ph.D. in Systems Design Engineering (University of Waterloo). Her work is focused on translational research for therapeutic enhancement of prostate-cancer treatment using multimodal gold nanoparticles.
Samantha holds an Honours B.Sc. in Biomedical Sciences (Minor in Psychology) from the University of Waterloo. Her project focuses on the development novel transdermal delivery systems in partnership with Avro Life Sciences.
Jiahao holds a B.Sc. in Pharmaceutical Science from Shenyang Pharmaceutical University in China. He works on polymer-lipid matrix supersaturated drug delivery systems for the oral delivery of poorly soluble drugs.
Scott holds an Honours B.Sc. in Chemistry, Pharmaceutical Chemistry Specialization, from the University of Ontario Institute of Technology in Oshawa, Ontario. His project focuses on the study of Langmuir monolayers of gemini surfactants and model cellular membranes to optimize drug delivery systems.
Gurmeet holds an Honours B.Sc. in Biomedical Sciences from the University of Waterloo. Her project focuses on studying the disruptions of model cellular membranes by surface active components of drug delivery systems using Langmuir monolayer methods.
Mohamed is a graduate from the University of Waterloo Nanotechnology Engineering program. His project focuses on the development of a gold nanoparticle based therapy for use in the treatment of prostate cancer.
Ahsan holds a B.Sc. in General Science from Mount Royal University in Calgary with a core focus on chemistry and physics. He is currently working on the design and development of a novel drug-delivery system for primary brain tumors such as Glioblastomas.
